- Home
- CYCC vs SXTP Comparison
CYCC vs SXTP Comparison
Compare CYCC & SXTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYCC
- SXTP
- Stock Information
- Founded
- CYCC 1992
- SXTP 2010
- Country
- CYCC Malaysia
- SXTP United States
- Employees
- CYCC N/A
- SXTP N/A
- Industry
- CYCC Biotechnology: Pharmaceutical Preparations
- SXTP Biotechnology: Pharmaceutical Preparations
- Sector
- CYCC Health Care
- SXTP Health Care
- Exchange
- CYCC Nasdaq
- SXTP Nasdaq
- Market Cap
- CYCC 8.3M
- SXTP 3.7M
- IPO Year
- CYCC N/A
- SXTP 2023
- Fundamental
- Price
- CYCC $0.24
- SXTP $2.34
- Analyst Decision
- CYCC
- SXTP Buy
- Analyst Count
- CYCC 0
- SXTP 2
- Target Price
- CYCC N/A
- SXTP $7.00
- AVG Volume (30 Days)
- CYCC 4.2M
- SXTP 118.8K
- Earning Date
- CYCC 08-13-2025
- SXTP 08-13-2025
- Dividend Yield
- CYCC N/A
- SXTP N/A
- EPS Growth
- CYCC N/A
- SXTP N/A
- EPS
- CYCC N/A
- SXTP N/A
- Revenue
- CYCC $14,000.00
- SXTP $802,323.00
- Revenue This Year
- CYCC $137.21
- SXTP $95.50
- Revenue Next Year
- CYCC N/A
- SXTP $80.78
- P/E Ratio
- CYCC N/A
- SXTP N/A
- Revenue Growth
- CYCC N/A
- SXTP 118.37
- 52 Week Low
- CYCC $0.22
- SXTP $1.41
- 52 Week High
- CYCC $39.84
- SXTP $35.99
- Technical
- Relative Strength Index (RSI)
- CYCC 24.28
- SXTP 49.40
- Support Level
- CYCC $0.31
- SXTP $2.31
- Resistance Level
- CYCC $0.34
- SXTP $2.49
- Average True Range (ATR)
- CYCC 0.05
- SXTP 0.18
- MACD
- CYCC 0.10
- SXTP 0.01
- Stochastic Oscillator
- CYCC 8.57
- SXTP 75.24
About CYCC Cyclacel Pharmaceuticals Inc.
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib. The company derives its revenue from United Kingdoms.
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.